Novalar Pharmaceuticals novalarpharm.com


Public list: Smart Money VCs (6328) Pharma Startups (4732)

Novalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the speech impediments, lip biting, and difficulty in eating that can be caused by unintended soft-tissue anesthesia.

Novalar is developing a drug agent that is designed to reverse the effects of local anesthesia applied in dental procedures, thereby allowing patients to return to their daily activities without the speech impediments, lip biting, and difficulty in e...Show all

Company (Alive / Active)

Phone: 858-436-1100

Fax:

12555 High Bluff Drive
Suite 300
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Novalar Pharmaceuticals $58.5M Jul 7, 2010
Corcept Therapeutics $130.3M Mar 5, 2008
ConjuChem $28.5M Dec 2, 2000
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Novalar Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof Mar 18, 2005 Aug 18, 2009 Patent
Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof Dec 15, 2006 Aug 04, 2009 Patent